Alzheimer's vs other types of dementia — how are they different?

Published by Unseen Progress, an independent publisher of caregiver research. Last reviewed 2026-07-10. Part of the dementia caregiver research overview.

Short answer. Dementia is an umbrella term for a decline in memory and thinking severe enough to affect daily life; Alzheimer's disease is the single most common cause, accounting for an estimated 60–80% of cases (Alzheimer's Association, 2024). The other major types — vascular dementia, dementia with Lewy bodies (DLB), frontotemporal dementia (FTD), and mixed dementia — differ in their early symptoms, their course, and, importantly, in what care and what medications are safe. Dementia with Lewy bodies in particular is defined partly by well-formed visual hallucinations and marked antipsychotic sensitivity (McKeith et al., 2017), which makes getting the type right more than an academic exercise.

What the research says

"Dementia" describes a syndrome, not a single disease. Several distinct pathologies produce it, and while they overlap in the late stages, they diverge early — and that early divergence is where the type actually changes what a caregiver should do.

  • Alzheimer's disease is the most common cause (an estimated 60–80% of cases; Alzheimer's Association, 2024). It typically begins with short-term memory loss — recent conversations and events fade first — then spreads to language, orientation, and reasoning.
  • Vascular dementia results from reduced blood flow to the brain, often after strokes or small-vessel disease. It can begin more abruptly or progress in a "stepwise" pattern, and early problems often centre on planning, judgment, and processing speed rather than pure memory.
  • Dementia with Lewy bodies (DLB) is defined by a cluster of core features: fluctuating cognition and alertness, recurrent well-formed visual hallucinations, REM sleep behaviour disorder, and spontaneous parkinsonism (McKeith et al., 2017). People with DLB are frequently severely sensitive to antipsychotic medications, which can cause dangerous reactions.
  • Frontotemporal dementia (FTD) tends to strike younger and often begins with changes in personality, behaviour, or language rather than memory — apathy, loss of social filter, or progressive difficulty with words — which is why it is frequently mistaken for a psychiatric condition early on.
  • Mixed dementia — most often Alzheimer's pathology combined with vascular disease — is common, especially in older people, and the Alzheimer's Association (2024) notes it may be more frequent than once assumed.

The practical upshot from Gitlin, Kales, and Lyketsos (2012): the care principles (decode behaviour as unmet need, favour nonpharmacologic approaches first) apply across types, but the specific risks and early symptom profile differ by type — and DLB's antipsychotic sensitivity is the clearest example of why the diagnosis matters.

The major types compared

Individual cases blur these lines, and mixed pathology is common — but the early profile is usually the most distinguishing feature.

TypeShare / frequencyTypical early symptomsDistinguishing featuresCare note
Alzheimer's diseaseMost common (~60–80%)Short-term memory loss; word-finding; disorientationGradual, steady progressionStandard dementia care principles apply
Vascular dementiaSecond most commonSlowed thinking, planning/judgment problemsStepwise or abrupt course; stroke historyManage vascular risk factors; watch for further events
Dementia with Lewy bodies (DLB)Common among the primary typesFluctuating alertness; visual hallucinations; movement changesRecurrent well-formed hallucinations, REM sleep disorder, parkinsonism (McKeith et al., 2017)Severe antipsychotic sensitivity — flag the diagnosis before any antipsychotic
Frontotemporal dementia (FTD)Less common; younger onsetPersonality/behaviour change or language declineMemory often relatively spared earlyBehaviour-first strategies; often misread as psychiatric
Mixed dementiaCommon in older adultsBlend of the above (often AD + vascular)Overlapping pathologiesAddress both mechanisms

Why getting the type right matters

For many caregivers the day-to-day work looks similar across types — structure, cueing, decoding behaviour, matching support to stage. But three differences change decisions:

1. DLB and antipsychotics. Because people with dementia with Lewy bodies can react severely to antipsychotic drugs (McKeith et al., 2017), a DLB diagnosis should be on the record before any such medication is considered for hallucinations or agitation. This is the single highest-stakes reason to pin down the type. 2. Vascular risk. In vascular and mixed dementia, controlling blood pressure, diabetes, and other vascular risk factors can influence the course — a lever that doesn't exist in the same way for pure Alzheimer's. 3. FTD's early behaviour. When personality or language change comes before memory loss, families and even clinicians may look in the wrong direction for months. Recognising the FTD pattern reframes the behaviour as neurological, not willful — which changes both the response and the caregiver's self-blame.

Across all types, the nonpharmacologic-first stance holds (Gitlin, Kales, & Lyketsos, 2012): investigate behaviour as communication, adjust the environment, and reserve medication for what doesn't respond — with DLB as the standing caution about which medications are safe.

How families ask this

  • "What's the difference between Alzheimer's and dementia?"
  • "Is Lewy body dementia different from Alzheimer's?"
  • "My mom sees people who aren't there — is that Alzheimer's?" (often points toward DLB)
  • "My dad's personality changed before his memory — what kind of dementia is that?" (often points toward FTD)
  • "Can you have more than one type of dementia at once?" (yes — mixed dementia)

The recurring confusion is treating "dementia" and "Alzheimer's" as synonyms. Dementia is the umbrella; Alzheimer's is the most common cause under it — and the other causes differ in ways that occasionally change what is safe to do.

References

  • Alzheimer's Association. (2024). 2024 Alzheimer's Disease Facts and Figures. Alzheimer's & Dementia, 20(5).
  • McKeith, I. G., Boeve, B. F., Dickson, D. W., et al. (2017). Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology, 89(1), 88–100.
  • Gitlin, L. N., Kales, H. C., & Lyketsos, C. G. (2012). Nonpharmacologic management of behavioral symptoms in dementia. JAMA, 308(19), 2020–2029.

---

Unseen Progress publishes long-form caregiver research. See the full dementia caregiver research overview for the complete framework.